Pathobiology of Anaplastic Large Cell Lymphoma

by Pier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, Claudio Agostinelli, Francesco Bacci, Elena Sabattini, Carlo Sagramoso, Roberto Piva, Fernando Roncolato, Giorgio Inghirami, Stefano A. Pileri
Published 2010-01-01

Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia

by Maura Rossi, Fabio Fuligni, Maria Ciccone, Claudio Agostinelli, Simona Righi, Marco Luciani, Maria Antonella Laginestra, Gian Matteo Rigolin, Maria Rosaria Sapienza, Anna Gazzola, Claudia Mannu, Antonio Cuneo, Stefano Pileri, Pier Paolo Piccaluga
Published 2013-01-01

Pathobiology of Hodgkin Lymphoma

by Pier Paolo Piccaluga, Claudio Agostinelli, Anna Gazzola, Claudio Tripodo, Francesco Bacci, Elena Sabattini, Maria Teresa Sista, Claudia Mannu, Maria Rosaria Sapienza, Maura Rossi, Maria Antonella Laginestra, Carlo A. Sagramoso-Sacchetti, Simona Righi, Stefano A. Pileri
Published 2011-01-01

SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis.

by Giuseppe Visani, Maria Rosaria Sapienza, Alessandro Isidori, Claudio Tripodo, Maria Antonella Laginestra, Simona Righi, Carlo A Sagramoso Sacchetti, Anna Gazzola, Claudia Mannu, Maura Rossi, Michele De Nictolis, Massimo Valentini, Meris Donati, Roberto Emiliani, Francesco Alesiani, Stefania Paolini, Carlo Finelli, Stefano A Pileri, Pier Paolo Piccaluga
Published 2011-01-01

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network

by Barbara Mantoan, Elisa Genuardi, Martina Ferrante, Irene Della Starza, Elena Ciabatti, Susanna Grassi, Lucia Anna De Novi, Marzia Cavalli, Claudia Mannu, Anna Gazzola, Riccardo Bomben, Massimo Degan, Beatrice Alessandria, Christiane Pott, Marie-Hélène Delfau-Larue, Ramon García-Sanz, Claudio Agostinelli, Valter Gattei, Sara Galimberti, Ilaria Del Giudice, Gianluca Gaidano, Marco Ladetto, Simone Ferrero, Daniela Drandi, on behalf of the Fondazione Italiana Linfomi (FIL) MRD Network
Published 2021-10-01